Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0001415889-24-027332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-20 | 2024-11-18 | VERA | Carter Jason S | CLO | A - Grant | $0.00 | +53.0K | 53.0K | New | $0 |
| D | 2024-11-20 | 2024-11-18 | VERA | Carter Jason S | CLO | A - Grant | $0.00 | +108.0K | 108.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-18 | A | A | 53,000 | $0.00 | 53,000 | D | — | — | (F1) Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs vest on each February 20, May 20, August 20 and November 20 following the vesting commencement date of November 18, 2024, subject to the Reporting Person's continuous service through each vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2024-11-18 | A | A | 108,000 | $0.00 | 108,000 | D | $44.81 · — to 2034-11-17 | 108,000 Class A Common Stock | (F2) 1/4 of the shares subject to the option vest on November 18, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date. |